SMT201700010B - Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola - Google Patents

Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola

Info

Publication number
SMT201700010B
SMT201700010B SM201700010T SM201700010T SMT201700010B SM T201700010 B SMT201700010 B SM T201700010B SM 201700010 T SM201700010 T SM 201700010T SM 201700010 T SM201700010 T SM 201700010T SM T201700010 B SMT201700010 B SM T201700010B
Authority
SM
San Marino
Prior art keywords
local
bupivacaine
throat
mouth
pharmaceutical compositions
Prior art date
Application number
SM201700010T
Other languages
English (en)
Inventor
Ove Andersen
Stine Mogensen
Charlotte Treldal
Sylvia Pulis
Torben Mogensen
Original Assignee
Moberg Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moberg Pharma Ab filed Critical Moberg Pharma Ab
Publication of SMT201700010B publication Critical patent/SMT201700010B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201700010T 2011-04-29 2017-01-10 Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola SMT201700010B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201170213 2011-04-29
DKPA201170225 2011-05-06
PCT/EP2012/057864 WO2012146763A1 (en) 2011-04-29 2012-04-27 Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat

Publications (1)

Publication Number Publication Date
SMT201700010B true SMT201700010B (it) 2017-03-08

Family

ID=59078879

Family Applications (3)

Application Number Title Priority Date Filing Date
SM20210228T SMT202100228T1 (it) 2011-04-29 2012-04-27 Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola
SM20170010T SMT201700010T1 (it) 2011-04-29 2012-04-27 Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola
SM201700010T SMT201700010B (it) 2011-04-29 2017-01-10 Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SM20210228T SMT202100228T1 (it) 2011-04-29 2012-04-27 Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola
SM20170010T SMT201700010T1 (it) 2011-04-29 2012-04-27 Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola

Country Status (15)

Country Link
US (2) US9956211B2 (it)
EP (3) EP2701681B1 (it)
CA (2) CA2972211C (it)
CY (2) CY1118474T1 (it)
DK (2) DK2701681T3 (it)
ES (2) ES2857252T3 (it)
HR (2) HRP20161444T1 (it)
HU (2) HUE030921T2 (it)
LT (2) LT3284459T (it)
PL (2) PL2701681T3 (it)
PT (2) PT3284459T (it)
RS (2) RS61753B1 (it)
SI (2) SI3284459T1 (it)
SM (3) SMT202100228T1 (it)
WO (1) WO2012146763A1 (it)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT202100228T1 (it) * 2011-04-29 2021-05-07 Moberg Pharma Ab Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola
PL3409271T3 (pl) * 2012-05-16 2024-11-18 Orexa B.V. Środki znieczulające miejscowo dla ułatwienia przyjmowania i retencji pokarmu
CA2973178C (en) * 2015-01-06 2022-11-01 Cellix Bio Private Limited Bupivacaine derivatives and their use in the treatment of inflammation and pain
CN104758592A (zh) * 2015-04-11 2015-07-08 河南金鸿堂制药有限公司 一种治疗风火牙痛的中药胶囊制剂
US20200297734A1 (en) 2015-06-19 2020-09-24 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
US10555952B2 (en) 2015-06-19 2020-02-11 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
RU2604576C1 (ru) * 2015-12-01 2016-12-10 Общество С Ограниченной Ответственностью "Валента - Интеллект" Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний местного применения и способ ее получения и применения
US12102729B2 (en) 2017-08-04 2024-10-01 Hcs Innovation, Llc Natural polymer-based tissue adhesive with healing-promoting properties
US10835635B2 (en) 2017-08-04 2020-11-17 Hcs Innovation, Llc Natural polymer based tissue adhesive with healing promoting properties
US11571492B2 (en) 2017-08-04 2023-02-07 Hcs Innovation, Llc Natural polymer-based tissue adhesive with healing-promoting properties
WO2019231858A1 (en) * 2018-06-01 2019-12-05 Melt Pharmaceuticals, Inc. Pharmaceutical compositions and methods for anesthesiological applications
CA3158116A1 (en) * 2019-10-14 2021-04-22 Tate & Lyle Solutions Usa Llc Flavor altering and/or sweetness enhancing compositions and methods and food and beverage products based thereon
US20230080593A1 (en) 2020-01-10 2023-03-16 Pacira Pharmaceuticals, Inc. Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions
EP4087568A4 (en) 2020-01-10 2024-01-17 Pacira Pharmaceuticals, Inc. Treatment of pain by administration of sustained-release liposomal anesthetic compositions
KR20230110562A (ko) * 2020-11-21 2023-07-24 셀릭스 바이오 프라이빗 리미티드 통증 관리 및 치료에 사용하기 위한 약학 조성물
BR112023013685A2 (pt) 2021-01-11 2023-11-14 Pacira Pharmaceuticals Inc Tratamento da dor no quadril com composições anestésicas lipossômicas de liberação sustentada
BR112023018896A2 (pt) * 2021-03-19 2023-10-10 Pacira Pharmaceuticals Inc Tratamento da dor em pacientes pediátricos por administração de composições anestésicas lipossômicas de liberação prolongada
WO2023187664A1 (en) * 2022-03-30 2023-10-05 Avaca Pharma Private Limited A pharmaceutical composition for the treatment of immune system mediated diseases
EP4590302A2 (en) * 2022-09-22 2025-07-30 Rythera Therapeutics Inc. Composition and method for prevention and treatment of cutaneous radiation injury
US11918565B1 (en) 2022-11-03 2024-03-05 Pacira Pharmaceuticals, Inc. Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions
US12226610B2 (en) 2022-11-03 2025-02-18 Pacira Pharmaceuticals, Inc. Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions
WO2025170507A1 (en) * 2024-02-07 2025-08-14 Oncozenge Ab A lozenge

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511914A (en) 1967-01-31 1970-05-12 Schering Corp Throat lozenge vehicle
GB2133284A (en) 1983-01-07 1984-07-25 English Grains Limited Resilient pharmaceutical unit for treating mouth ulcers
US4853212A (en) 1987-07-13 1989-08-01 Warner-Lambert Company Reduced base content chewing gum compositions having anesthetic properties
US4822597A (en) 1987-07-13 1989-04-18 Warner-Lambert Company Anesthetic-containing chewing gum compositions
GB8810951D0 (en) 1988-05-09 1988-06-15 Innovata Biomed Ltd Buccal local anaesthetic
GB8928196D0 (en) 1989-12-13 1990-02-14 Merrell Dow Pharmaceuticals Li Pharmaceutical lozenges
US6221840B1 (en) 1991-02-14 2001-04-24 The General Hospital Corporation Intestinal trefoil proteins
US5332576A (en) 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
WO1994008550A1 (en) 1992-10-09 1994-04-28 The Procter & Gamble Company Anaesthetic compositions
US5399354A (en) 1993-05-28 1995-03-21 Mcneil-Ppc, Inc. Process for making a hard-candy based oral pharmaceutical lozenge containing an antacid
US20030186884A1 (en) 2000-06-08 2003-10-02 Markland Francis S. Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
US5713852A (en) 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
NZ311474A (en) 1995-06-09 1997-09-22 Euro Celtique Sa Formulations for providing prolonged local anesthesia
US5614207A (en) 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
US5912007A (en) 1996-02-29 1999-06-15 Warner-Lambert Company Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
PT906089E (pt) 1996-05-13 2004-01-30 Novartis Consumer Health Sa Sistema de administracao bucal
WO1997049391A1 (en) 1996-06-24 1997-12-31 Euro-Celtique, S.A. Methods for providing safe local anesthesia
WO1997049384A1 (en) 1996-06-26 1997-12-31 Board Of Regents, The University Of Texas System Hot-melt extrudable pharmaceutical formulation
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
GB9710521D0 (en) 1997-05-22 1997-07-16 Boots Co Plc Process
US8765177B2 (en) 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6103257A (en) * 1998-07-17 2000-08-15 Num-Pop, Inc. System for delivering pharmaceuticals to the buccal mucosa
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US6946118B1 (en) 1999-09-14 2005-09-20 Orapharma, Inc. Formulations for treating or preventing mucositis
US6264981B1 (en) 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
KR20030060771A (ko) 2000-04-28 2003-07-16 메모리얼 슬로안-케터링 캔서 센터 국소용 마취제/아편양약물 제제 및 이들의 용도
WO2001089476A1 (en) 2000-05-19 2001-11-29 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US20020013331A1 (en) 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
EP1559418A1 (en) 2000-06-26 2005-08-03 EpiCept Corporation Compositions for treating pain of the mucous membrane
MXPA03004546A (es) 2000-11-22 2003-09-10 Rxkinetix Inc Tratamiento de mucositis.
EP1236466B1 (en) * 2001-02-28 2011-09-21 Axiomedic Ltd. Solid self-adhesive compositions for topical treatment of oral mucosal disorders
EP1387672A1 (en) 2001-04-17 2004-02-11 Wm. Wrigley Jr. Company Flavored product containing medicament or other active agent
US7820688B2 (en) 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
EP1420798A4 (en) 2001-08-10 2007-07-25 Eisai Co Ltd TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS RELATED TO HEAT SHOCK PROTEIN
US7470545B2 (en) 2001-11-05 2008-12-30 Rohm And Haas Company Buccal dissolution of active substances
US20030114534A1 (en) 2001-12-17 2003-06-19 Peter Arsenault Pharmaceutical preparation for apthous ulcers
US20030175360A1 (en) * 2002-02-22 2003-09-18 Renzo Luzzatti Symptomatic relief of gastrointestinal disorders
US7074426B2 (en) 2002-03-27 2006-07-11 Frank Kochinke Methods and drug delivery systems for the treatment of orofacial diseases
US6919348B2 (en) 2002-05-02 2005-07-19 Edward T. Wei Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
CA2501614A1 (en) 2002-10-07 2004-04-22 Orapharma, Inc. Mucoadhesive tetracycline formulations
JP5204947B2 (ja) 2002-11-27 2013-06-05 ディーエムアイ バイオサイエンシズ インコーポレイテッド リン酸受容体化合物の使用、ならびにリン酸受容体化合物を含んでいる、薬学的組成物、スキンケア用の組成物、およびキット
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
US20040151771A1 (en) 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
CN1777411B (zh) 2003-02-24 2013-01-02 药品生产公司 经粘膜药物递送系统
CN1761458A (zh) 2003-05-02 2006-04-19 沃尼尔·朗伯有限责任公司 用于向咽喉递送药物活性剂的糖果产品
US7713440B2 (en) 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
US20050152972A1 (en) * 2004-01-14 2005-07-14 Mohinder Singh Soft chewable anesthetic lozenges
US7452523B2 (en) 2004-01-27 2008-11-18 Gilead Sciences, Inc. Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
JP4252497B2 (ja) 2004-06-07 2009-04-08 日東電工株式会社 上部消化管内視鏡検査前処置用局所麻酔製剤
DE202004016078U1 (de) 2004-09-22 2005-11-10 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Schleimdrogenbasierte Lutschtablette gegen entzündliche Erkrankungen des Mund- und Rachenraums
DE202004016077U1 (de) 2004-09-22 2005-11-10 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Lutschtablette gegen entzündliche Erkrankungen des Mund- und Rachenraums
DE102004052308B4 (de) 2004-10-12 2013-04-04 Divapharma-Knufinke Arzneimittelwerk Gmbh Octenidinhaltige Lutschtabletten gegen entzündliche Erkrankungen des Mund- und Rachenraums
IL166114A0 (en) 2005-01-03 2006-01-15 Calcident Active Ltd Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
JP5144277B2 (ja) 2005-01-14 2013-02-13 カムルス エービー 局所用生体付着性製剤
US20060263306A1 (en) 2005-05-19 2006-11-23 Pauline Pan Compositions having improved substantivity
US20060280695A1 (en) 2005-06-08 2006-12-14 Giles Brian C Methods and compositions for the prevention, suppression and elimination of oral pain
US20070042027A1 (en) 2005-08-22 2007-02-22 Haley Jeffrey T Water soluble anesthetic in an oral patch of hydrophilic gums
US20070048338A1 (en) 2005-08-26 2007-03-01 Ladd Byron S Compositions and methods for surface treatment in medical and surgical procedures
CA2636061C (en) 2006-01-27 2015-06-02 Cadbury Adams Usa Llc Flavor-enhancing compositions, methods of manufacture, and methods of use
EP2015761A4 (en) 2006-03-29 2009-07-29 Naveh Pharma 1996 Ltd METHOD AND COMPOSITION FOR THE TREATMENT OF NUTRITIONAL IGNITION
US20100247453A1 (en) 2006-07-12 2010-09-30 Thomas L. Jones Composition and method of treating a sore throat
WO2008060764A2 (en) 2006-10-05 2008-05-22 Drugtech Corporation Topical therapies for oral mucositis and other conditions
US9855279B2 (en) 2006-10-12 2018-01-02 Galera Labs, Llc Methods of treating oral mucositis
DE502006006810D1 (de) 2006-11-06 2010-06-02 Lohmann & Rauscher Gmbh & Co Produkt zur Versorgung von Entzündungen, Druckstellen und/oder Aphten im Oralbereich sowie Verwendung eines solchen Produkts
US20080146672A1 (en) 2006-12-08 2008-06-19 Denton Marcia Marye Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue
US20090081291A1 (en) 2007-09-26 2009-03-26 Gin Jerry B Sustained Release Dosage Forms For Delivery of Agents to an Oral Cavity of a User
US20090081294A1 (en) 2007-09-26 2009-03-26 Gin Jerry B Sustained release dosage form for lubricating an oral cavity
CA2701583A1 (en) 2007-10-03 2009-04-09 Myrex Pharmaceuticals Inc. Mouthwash and method of using same for the treatment of mucositis or stomatitis
GB0722349D0 (en) 2007-11-15 2007-12-27 Reckitt Benckiser Healthcare Use of anti-bacterial compounds having an anaesthetic effect
CL2008003507A1 (es) 2007-11-26 2009-11-27 Neuroderm Ltd Composicion farmaceutica que comprende nicotina y un inhibidor de la desensibilizacion del receptor de acetilcolina nicotinico (nachr) opipramol; kit farmaceutico; dispositivo medico; y uso para tratar una enfermedad o trastorno del sistema nervioso central o periferico.
DE102008034748A1 (de) 2008-07-24 2010-01-28 Tesa Se Flexibles beheiztes Flächenelement
DE102009005865A1 (de) 2009-01-07 2010-07-08 Klosterfrau Berlin Gmbh Dosiereinheit und Zusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums
EP2432322A4 (en) 2009-05-20 2013-07-03 Mineral Science Co OPTIMAL COMPOSITIONS AND METHODS OF TREATING ORAL DISEASES AND PAIN
SMT202100228T1 (it) * 2011-04-29 2021-05-07 Moberg Pharma Ab Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola

Also Published As

Publication number Publication date
HRP20210487T1 (hr) 2021-05-14
CY1118474T1 (el) 2017-07-12
EP3284459A1 (en) 2018-02-21
RS61753B1 (sr) 2021-05-31
ES2857252T3 (es) 2021-09-28
CA2972211A1 (en) 2012-11-01
HUE053776T2 (hu) 2021-07-28
PL3284459T3 (pl) 2021-06-28
CY1124219T1 (el) 2022-05-27
PT3284459T (pt) 2021-03-30
CA2860373C (en) 2017-08-15
SMT201700010T1 (it) 2017-03-08
PT2701681T (pt) 2016-12-16
EP2701681B1 (en) 2016-10-19
LT3284459T (lt) 2021-04-12
WO2012146763A1 (en) 2012-11-01
SMT202100228T1 (it) 2021-05-07
DK2701681T3 (en) 2017-01-09
DK3284459T3 (en) 2021-03-15
LT2701681T (lt) 2016-12-12
SI2701681T1 (sl) 2017-01-31
HUE030921T2 (en) 2017-06-28
ES2605814T3 (es) 2017-03-16
US20180221358A1 (en) 2018-08-09
CA2860373A1 (en) 2012-11-01
US10493068B2 (en) 2019-12-03
HRP20161444T1 (hr) 2016-12-16
CA2972211C (en) 2019-02-05
EP3173069A1 (en) 2017-05-31
US9956211B2 (en) 2018-05-01
EP2701681A1 (en) 2014-03-05
PL2701681T3 (pl) 2017-03-31
RS55372B1 (sr) 2017-03-31
SI3284459T1 (sl) 2021-07-30
US20140296293A1 (en) 2014-10-02
EP3284459B1 (en) 2021-01-06

Similar Documents

Publication Publication Date Title
SMT201700010B (it) Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola
CO6852076A2 (es) Composiciones farmacéuticas inhalables
HUE042291T2 (hu) Dózis számlálók inhalátorokhoz
EP2760417A4 (en) Oral care compositions
SMT201700050B (it) Composizioni anestetiche termogelificanti
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
PL2398464T3 (pl) Kompozycja farmaceutyczna do inhalacji
BR112014003052A2 (pt) composições farmacêuticas
EP2756840A4 (en) PHARMACEUTICAL COMPOSITIONS FOR INHALATION
DK3653223T3 (da) Enhed til oral levering af terapeutiske forbindelser
BR112013017169A2 (pt) composições farmacêuticas de ferro para administração oral
CO6930367A2 (es) Composiciones farmaceúticas
DK2800567T3 (da) En inhalator omfattende en tiotropium-indeholdende-sammensætning
EP2588127A4 (en) DIPEPTIDE-NETWORKED MEDICAL ACTIVE SUBSTANCES
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
HUE040370T2 (hu) Gyógyszerkészítmények
SMT201400192B (it) Medicamento inalabile comprendente tiotropio
HUE049273T2 (hu) A racekadotril új adagolási módja
EP2769718A4 (en) MEDICAL COMPOSITION
SMT201600342B (it) Composizioni farmaceutiche topiche comprendenti mometasone furoato
CO6801778A2 (es) Composiciones de cuidado oral
SMT201500005B (it) Composizione framaceutica inalabile
PL2818163T3 (pl) Kompozycja do podawania donosowego o ulepszonej stabilności
DK2714042T3 (da) En analgetisk farmaceutisk sammensætning til oral administration
HRP20220523T8 (hr) Prirodni ljekoviti spoj